August 14, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Eli Lilly files lawsuits against six companies for allegedly selling retatrutide
Eli Lilly and Co. has filed lawsuits against six companies that it claims are selling counterfeit, unapproved versions of its investigational diabetes and obesity drug, retatrutide, according to a press release. Eli Lilly stated in the release it chose to file lawsuits against six entities selling illegal versions of the glucose-dependent insulinotropic polypeptide (GIP)/GLP-1/glucagon triple
729 words~3 min read
